Origin Agritech Held Transgenic Breeding Seminar and Announces Partnerships with 12 Leading Agricultural Companies

Origin Agritech Held Transgenic Breeding Seminar and Announces Partnerships with 12 Leading Agricultural Companies

BEIJING, Jan. 17, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the signing of cooperation agreements (the "agreements") with 12 prominent...

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer

SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

HIXXHOME Smart Birdfeeder and CoolFly App recognized as a House Digest Best of CES 2025

HIXXHOME Smart Birdfeeder and CoolFly App recognized as a House Digest Best of CES 2025

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- A new smart birdfeeder from HIXXHOME and its companion app from CoolFly have been recognized by Home Digest as a Best of CES 2025 for their innovative features that enhance backyard birding. Participating in...

Timekettle CEO Leal Tian Joins Elite Panel on AI Innovation at Microsoft's Event During CES 2025

Timekettle CEO Leal Tian Joins Elite Panel on AI Innovation at Microsoft's Event During CES 2025

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- During CES 2025, Microsoft Greater China held a specialized event themed "Be AI Ready, Win Globally," focusing on empowering Chinese enterprises that are expanding into international markets. Key participant...

2024 Marks Breakout Year for China's ETF Market with Unprecedented Growth

2024 Marks Breakout Year for China's ETF Market with Unprecedented Growth

GUANGZHOU, China, Jan. 10, 2025 /PRNewswire/ -- China's ETF market demonstrated exceptional performance in 2024, with notable returns and substantial growth in assets under management. According to Wind, the average return of A-share ETFs (excl....

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

BEIJING, SHANGHAI and BOSTON, Jan. 7, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial of its independently developed...

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

VIVOTEK Wins Double Honors for Its Commitment to Sustainability

VIVOTEK Wins Double Honors for Its Commitment to Sustainability

TAIPEI, Dec. 26, 2024 /PRNewswire/ -- VIVOTEK (3454-TW), the global leading security solution provider, has once again demonstrated its outstanding commitment to sustainability. Participating for the first time in the 17th Taiwan Corporate...

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous ( SQ ) , once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily) , demonstrated superior weight loss compared to...

Fashion Icon Liu Wen Radiates Brilliance at Madame Tussauds Hong Kong Unveiling Event

Fashion Icon Liu Wen Radiates Brilliance at Madame Tussauds Hong Kong Unveiling Event

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Madame Tussauds Hong Kong, a brand under the Merlin Entertainment Group, proudly unveils the latest wax figure of internationally acclaimed model, Liu Wen. Visiting Madame Tussauds Hong Kong, Liu Wen...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • menu
    menu